Isotretinoin for Sebaceous Skin Lesions in Muir-Torre Syndrome: A Case Report

Marcusson, Jan A.; Bjarnason, Bolli; Ros, A-M.
October 1998
Acta Dermato-Venereologica;10/28/98, Vol. 78 Issue 6, p479
Academic Journal
Examines the effectiveness of isotretinoin for treating sebaceous skin lesions in Muir-Torre syndrome. Removal of low-to-average differentiated adenocarcinoma; Resections of adenocarcinoma infected colon and rectum; Development of skin cancer from sebaceous skin lesions.


Related Articles

  • Oral isotretinoin is as effective as a combination of oral isotretinoin and topical anti-acne agents in nodulocystic acne.  // Indian Journal of Dermatology, Venereology & Leprology;Mar/Apr2008, Vol. 74 Issue 2, following p188 

    An abstract of the article "Oral isotretinoin is as effective as a combination of oral isotretinoin and topical anti-acne agents in nodulocystic acne," by Rajeev Dhir, Neetu P. Gehi, Reetu Agarwal, and Yuvraj E. More is presented.

  • The diagnostic utility of inmunohistochemical and electronic microscopy in distinguishing between pleural mesothelioma and adenocarcinoma. Carrillo C., Carlos González; Malagón, Hugo Dominguez; Arrieta, Oscar // BMC Cancer;2007 Supplement 1, Vol. 7, pA32 

    An abstract of the article "The diagnostic utility of inmunohistochemical and electronic microscopy in distinguishing between pleural mesothelioma and adenocarcinoma," by Carlos González Carrillo C., Hugo Dominguez Malagón, and Oscar Arrieta is presented.

  • A call to redefine where cancer begins. Randal, Judith // JNCI: Journal of the National Cancer Institute;1/18/95, Vol. 87 Issue 2, p73 

    Reports on National Cancer Institute Laboratory of Chemoprevention head Michael Sporn's emphasis on the need for a redefinition of cancer to encompass the entire process of carcinogenesis. Self-limited nature of carcinogenesis; Results of retinoid studies; Waun Ki Hong's proposal for a study on...

  • Manufacturer, FDA revise isotretinoin labeling.  // Dermatology Times;Apr2002, Vol. 23 Issue 4, p9 

    Focuses on the revised isotretinoin labeling prescribed by dermatologists. Approval of the revision by the Food and Drug Administration; Efforts to minimize risk for adverse effects in isotretinoin effects; Importance of safety controls similar to Hoffman-La Roche.

  • A Pregnancy-Prevention Program in Women of Childbearing Age Receiving Isotretinoin. Mitchell, Allen A.; Van Bennekom, Carla M.; Louik, Carol // New England Journal of Medicine;7/13/95, Vol. 333 Issue 2, p101 

    Background: Isotretinoin is effective in treating severe acne, but it is also teratogenic. To minimize pregnancies among exposed women, the manufacturer, together with the U.S. Food and Drug Administration, implemented a multicomponent Pregnancy Prevention Program in 1988. We report the results...

  • A Pilot Study of Isotretinoin in the Treatment of Juvenile Chronic Myelogenous Leukemia. Castleberry, Robert P.; Emanuel, Peter D.; Zuckerman, Kenneth S.; Cohn, Susan; Strauss, Lewis; Byrd, Rebecca L.; Homans, Alan; Chaffee, Sarah; Nitschke, Ruprecht; Gualtieri, Richard J. // New England Journal of Medicine;12/22/94, Vol. 331 Issue 25, p1680 

    Background: Juvenile chronic myelogenous leukemia (CML) is a rare myeloproliferative disease of infants and young children for which there is no effective therapy other than allogeneic bone marrow transplantation. In vitro, isotretinoin (13-cis-retinoic acid) attenuates both the spontaneous...

  • Isotretinoin 5 mg daily for low-grade adult acne vulgaris - a placebo-controlled, randomized double-blind study. Schauber, Jürgen // Current Medical Literature: Dermatology;2013, Vol. 18 Issue 3, p75 

    A review of the article "Isotretinoin 5 mg Daily for Low-Grade Adult Acne Vulgaris-A Placebo-Controlled, Randomized Double-Blind Study ," which appeared in the periodical "Journal of European Academy of Dermatology and Venereol" on April 26, 2013 is presented.

  • High Risk for Hyperlipidemia and the Metabolic Syndrome after an Episode of Hypertriglyceridemia during 13-cis Retinoic Acid Therapy for Acne: A Pharmacogenetic Study. Rodondi, Nicolas; Darioli, Roger; Ramelet, Albert-Adrien; Hohl, Daniel; Lenain, Vincent; Perdrix, Jean; Wietlisbach, Vincent; Riesen, Walter F.; Walther, Thomas; Medinger, Laurent; Nicod, Pascal; Desvergne, Béatrice; Mooser, Vincent // Annals of Internal Medicine;4/16/2002, Vol. 136 Issue 8, p582 

    Background: Administration of 13-cis retinoic acid (isotretinoin) for acne is occasionally accompanied by hyperlipidemia. It is not known why some persons develop this side effect. Objective: To determine whether isotretinoin triggers a familial susceptibility to hyperlipidemia and the metabolic...

  • Isotretinoin.  // Reactions Weekly;2/6/2010, Issue 1287, p28 

    The article describes the case of a teenage boy who developed a perioral abscess while being treated with isotretinoin for severe scarring acne.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics